Crossject is revolutionizing needle free injection

Paragraphes
Colonne 1

Crossject is revolutionizing the administration of well-established, clinically-proven treatments and bringing unprecedented advantages to patients with its innovative, needle-free auto-injector ZENEO®. The prefilled, single-use device propels the medicine through the skin in only 50 milliseconds. Crossject currently has eight ZENEO® solutions in advanced stages of development, seven of which are for emergency situations.  

Zeneo illustration

 

Our news

Image de l'actualité

ZENEO® receives the JANUS

Résumé de l'actualité

Crossject is proud to announce that ZENEO® received the 2017 JANUS Prospective award from the French Institute of Design. 

Image de l'actualité
Conference room

Conference calendar

Résumé de l'actualité

Starting in autumn, Crossject will be attending renowned international conferences in Europe and the United States.

Image

Financial news: Business update

Sommaire ou résumé
  • Production resumed on the PARC® line
  • Schedule of marketing authorisation filings confirmed